Prognostic Value of the Circumferential Resection Margin After Curative Surgery For Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Galvez, Ana
- Biondo, Sebastiano
- Trenti, Loris
- Espin, Eloy
- Kraft, Miquel
- Farres, Ramon
- Codina-Cazador, Antonio
- Enriquez-Navascues, Jose M.
- Borda-Arrizabalaga, Nerea
- Kreisler, Esther
Grupos
Abstract
BACKGROUND: In the past few years, positive circumferential resection margin has been found to be an indicator of advanced disease with high risk of distant recurrence rather than of local recurrence. OBJECTIVE: The objective was to analyze the prognostic impact of circumferential resection margin on local recurrence, distant recurrence, and survival rates in patients with rectal cancer. DESIGN: This was a multicenter, propensity score-matched analysis 2:1 comparing positive and negative circumferential resection margin. SETTINGS: The study was conducted at 5 high-volume centers in Spain. PATIENTS: Patients who underwent total mesorectal excision with a curative intent for middle-low rectal cancer between 2006 and 2014 were included. Clinical and histological characteristics were used for matching. MAIN OUTCOME MEASURES: The main outcomes were local recurrence, distant recurrence, overall survival, and disease-free survival. RESULTS: The unmatched initial cohort consisted of 1599 patients; 4.9% had a positive circumferential resection margin. After matching, 234 patients were included (156 with negative circumferential margin and 78 with positive circumferential margin). The median follow-up period was 52.5 months (22.0-69.5). Local recurrence was significantly higher in patients with positive circumferential margin (33.3% vs 11.5%; HR 3.2; 95% CI: 1.83-5.43; p < 0.001). Distant recurrence was similar in both groups (46.2% vs 42.3%; HR 1.09; 95% CI: 0.78-1.90; p = 0.651). There were no statistically significant differences in 5-year overall survival (48.6% vs 43.6%; HR 1.09; 95% CI: 0.92-1.78; p = 0.14). Disease-free survival was lower in patients with positive circumferential margin (36.1% vs 52.3%; HR 1.5; 95% CI: 1.05-2.06; p = 0.026). LIMITATIONS: This study was limited by its retrospective design. The different neoadjuvant treatment options were not been included in the propensity score. CONCLUSIONS: Positive circumferential resection margin is associated with higher local recurrence rate and worse disease-free survival in comparison with negative circumferential resection margin. However, positive circumferential resection margin was not a prognostic indicator of distant recurrence and overall survival. See Video Abstract at http://links.lww.com/DCR/B950.
Copyright © The ASCRS 2022.
Datos de la publicación
- ISSN/ISSNe:
- 0012-3706, 1530-0358
- Tipo:
- Article
- Páginas:
- 887-897
- PubMed:
- 35348529
- Factor de Impacto:
- 1,120 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
DISEASES OF THE COLON & RECTUM LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Proyectos y Estudios Clínicos
MODELOS DE HÍGADO AISLADO PERFUNDIDO PARA EL RESCATE DE ÓRGANOS Y TRASLACIÓN DE LA TERAPIA GÉNICA EN EL TRASPLANTE: ESCENARIOS HUMANO "EX VIVO" Y PORCINO "IN VIVO"
Investigador Principal: RAFAEL LÓPEZ ANDÚJAR
2017_0270_CRC_LOPEZ . FUNDACION MUTUA MADRILEÑA . 2017
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.
Investigador Principal: MATTEO FRASSON
2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018
Terápia génica no-viral con 1L 10 para el tratamiento de la enfermedad inflamatoria intestinal. Estudio preliminar con piezas de cólon humano ex vivo.
Investigador Principal: MATTEO FRASSON
PI18/01658 . INSTITUTO DE SALUD CARLOS III . 2019
Trocar multisensor para cirugía laparoscópica con presión de pneumoperitoneo individualizada
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
INNVAL10/18/056 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2018
INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPEGASUS . 2017
MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
ODC-MOR-2018-01
ESTUDIO PROSPECTIVO, ALEATORIZADO, DOBLE-CIEGO, INTERNACIONAL Y MULTICÉNTRICO SOBRE LA SEGURIDAD Y LA EFICACIA DE LA SOLUCIÓN 6% HIDROXIETIL ALMIDÓN (HYDROXYETHYL STARCH) (HES) COMPARADA CON UNA SOLUCIÓN ELECTROLÍTICA EN PACIENTES SOMETIDOS A CIRUGÍA ABDOMINAL: ESTUDIO PHOENICS.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
HC-G-H-1504 (PHOENICS) . 2018
CHAIMELEON. ACCELERATING THE LAB TO MARKET TRANSITION OF AI TOOLS FOR CANCER MANAGEMENT.
Investigador Principal: LUIS MARTÍ BONMATÍ
952172 . COMISION EUROPEA . 2020
PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPPCOLLAPSE-II . 2016
ESTUDIO ALEATORIZADO MULTICÉNTRICO EN FASE III DE RADIOTERAPIA DE CORTA DURACIÓN SEGUIDA DE QUIMIOTERAPIA PREOPERATORIA DE LARGA DURACIÓN Y CIRUGÍA EN EL CÁNCER RECTAL PRIMARIO DE ALTO RIESGO EN COMPARACIÓN CON QUIMIORRADIOTERAPIA CONVENCIONAL Y CIRUGÍA Y OPTIMA QUIMIOTERAPIA ADYUVANTE.
Investigador Principal: JORGE APARICIO URTASUN
RAPIDO
Cita
Galvez A,Biondo S,Trenti L,Espin E,Kraft M,Farres R,Codina A,FLOR B,GARCIA E,Enriquez JM,Borda N,Kreisler E. Prognostic Value of the Circumferential Resection Margin After Curative Surgery For Rectal Cancer: A Multicenter Propensity Score-Matched Analysis. Dis Colon Rectum. 2022. 66. (7):p. 887-897. IF:3,900. (1).